Adjuvant and immunomodulatory potential of Natural Killer T (NKT) activation by NKTT320
N. G. Bond, M. D. Fahlberg, S. Yu, N. Rout, D. Tran, T. Fitzpatrick-Schmidt, L. M. Sprehe, E. A. Scheef, J. C. Mudd, R. G. Schaub, A. Kaur
This study evaluates the adjuvant and immunomodulatory effects of NKTT320, a humanized monoclonal antibody that activates iNKT cells, showing enhanced immune responses and inflammation resolution.
bioRxiv · Apr 27, 2021 · PreprintImmunology